PRIVATE INVESTMENTS FEED HOT
BIOTECH IPO MARKET
"IOTECHNOLOGYûCOMPANIESûAREûENJOYINGûAû
RECORDûYEARûOFûFUNDING ûBOTHûINûTHEûPRIVATEû
ANDûPUBLICûEQUITYûMARKETS
3ILICONû6ALLEYû"ANKû36" ûAûLEADINGû
MERCHANTûBANKERûTOûTHEûINDUSTRY ûPOINTSûTOû
INVESTMENTSûBYûTRADITIONAL ûLONG
ONLYûPUBLICû
funds in earlier VC rounds as a reason
BEHINDûTHEûSTRONGûINVESTMENTûCYCLE
2ATHERûTHANûWAITûUNTILû3ERIESû#ûORû$û
VENTURE
CAPITALûROUNDS ûSO
CALLEDûCROSSOVERû
INVESTORSûAREûSTAKINGûCLAIMSûINû!ûANDû"û
ROUNDS û36"ûSAIDûINûITSûMID
YEARûûREPORT û
ENTITLEDûh)NNOVATIONû7AVEû$RIVESû2OBUSTû
!CTIVITYv
4HEûMEDIANûSIZEûOFû3ERIESû!ûROUNDSûINûTHEû
lRSTûHALFûOFûTHEûYEARûWASûûLARGERûTHANûINû
ûANDû"ûROUNDSûWEREûûLARGERû
-OREOVER ûTHEûMEDIANûTIMEûFROMûTHEû
PRIVATEûCROSSOVERûTOû)0/ûWASûREDUCEDûTOû
SEVEN
AND
A
HALFûMONTHS ûVERSUSûABOUTûONEû
YEARûINû
“The biotech IPO window is rewarding
INVESTORSûWITHûQUICKûVALUATIONûSTEP
UPS vû
36"ûSAIDûINûTHEûREPORT
4HATûRAPIDûPRIVATE
TO
PUBLICûGESTATIONûHASû
CARRIEDûOVERûINTOûTHEûSECONDûHALFûOFûTHEûYEAR
RUBIUS THERAPEUTICS, a biotech
CHAMPIONINGûREDûBLOODûCELLSûTOûCUREû
DISEASES ûRAISEDû53MûONûITSû)0/ûLASTû
WEEK ûAûLITTLEûOVERûAûYEARûSINCEûITSû"ûROUNDû
lNANCING
-UTUALûFUNDûGIANTû&IDELITYû)NVESTMENTSû
ESTABLISHEDûITSûINITIALûPOSITIONûINûTHEû
COMPANYSû"ûROUNDûLASTû*UNEûANDûINCREASEDû
ITSûPRE
)0/ûSTAKEûTOûûINûAû&EBRUARYû#û
ROUND
2UBIUSûUPSIZEDûM
SHAREû)0/ûPRICEDû
ONû4UESDAYûATû53 ûAû
TIMESûSTEP
UPû
FROMûTHEû#ûROUNDûANDûVALUINGûTHEûCOMPANYû
ATû53BN
4HATûSEEMSûRICHûFORûAûCOMPANYûTHATûHASû
NOTûBEGUNûCLINICALûTRIALS ûTHOUGHû2UBIUSûDOESû
EXPECTûTOûlLEûAûNEWûDRUGûAPPLICATIONûFORûITSû
lRSTûCELLûTHERAPYûEARLYûNEXTûYEAR
ALLAKOSûISûANOTHERûEXAMPLE
4HEûCOMPANY ûINûPHASEû)))ûDEVELOPMENTû
OFûINmAMMATORYûDISEASEûTREATMENT û
GARNEREDûAû53BNûVALUATIONûONûITSû)0/û
ONû7EDNESDAY ûEIGHTûMONTHSûAFTERûITSû3ERIESû
"ûROUND
.EWû%NTERPRISEû!SSOCIATES ûAûTRADITIONALû
VENTUREûCAPITALûlRM ûANCHOREDûTHEû"ûROUNDû
ALONGûWITHûOTHERûCROSSOVERûINVESTORS ûANDû
AGREEDûTOûINVESTûANûADDITIONALû53MûINûAû
CONCURRENTûPRIVATEûPLACEMENTûTOûTHEû)0/
!LLAKOSû)0/ûPRICEDûATû53 ûAû
TIMESû
VALUATIONûSTEP
UPûFROMûTHEû"ûROUNDCOLOMBIA
COLOMBIA’S GEB WRAPS UP SECONDARY
STOCK SALE#OLOMBIASûGRUPO ENERGIA BOGOTAû'%" ûHASû
WRAPPEDûUPûANûALL
SECONDARYûSTOCKûSALEû
that further reduces the local
GOVERNMENTSûHOLDINGûINûTHEûSTATE
CONTROLLEDûUTILITY
Bank of America Merrill Lynch, BTG Pactual
ANDûLOCALûSHOPûInverlink PLANûTOûRELEASEû
PRICINGûDETAILSûONû-ONDAYûINûACCORDANCEû
WITHûLOCALûREGULATIONS
!TûAûBASEûSALEûOFûMûSHARESûFORûAû
MINIMUMûPRICEûOFû0S ûTHEûISSUERûWOULDûHAVEûGARNEREDûABOUTû53MûEQUIVALENTû
"UTûTHATûDOESNTûINCLUDEûANûOPTIONûTOûSELLû
ANOTHERûMûSHARES
'%"ûSHARESûTRADEDûATû0S ûONû&RIDAYû
morning, down from a recent high of
0S
4HEû#ITYûOFû"OGOTA ûTHEûSELLINGû
SHAREHOLDER ûOWNSûBNûSHARESûORûûOFû
THEûCOMPANY ûACCORDINGûTOû4HOMSONû
2EUTERSûDATA
7HILEûTHEûDEALûWASûMARKETEDûTOûFOREIGNû
INVESTORS ûITûWASûEXPECTEDûTOûBEûSOLDûLARGELYû
to local accounts, many of which already
OWNûTHEûSTOCK
h4HEREûISûAû!ûCOMPONENT ûBUTûTHEREû
AREûDEEPûPOCKETSûOFûMONEYûINû#OLOMBIAûWITHû
THEûPENSIONûFUNDSûANDûRETAILûFAMILYû
INVESTORS vûSAIDûAûBANKERûINVOLVEDûINûTHEû
UNDERWRITING
4HEûCOMPANY ûFORMERLYûNAMEDû%MPRESAû
DEû%NERGIAûDEû"OGOTAû%%" ûWENTûPUBLICûINû
COSTA RICA
ESTABLISHMENT GAINS LIFT IN
AFTERMARKETESTABLISHMENT LABS ûAûMAKERûOFûBREASTû
IMPLANTSûANDûAESTHETICS ûFOUNDûPLENTYûOFû
TAKERSûFORûANû)0/ûTHATûTHEû#OSTAû2ICANû
COMPANYûWILLûUSEûTOûFUNDûEXPANSIONûINTOûTHEû
53
Jefferies and CowenûPLACEDûMûSHARESûONû
7EDNESDAYûATû53 ûABOVEûTHEû53nû
MARKETINGûRANGEû%XISTINGûSHAREHOLDERSû
AGREEDûTOûINVESTûUPûTOû53MûINûTHEû
OFFERINGEQUITY-LINKED DEALS WEEK ENDING: 20/7/2018
Issuer Country Date Amount Greenshoe Tenor Coupon (%) Premium (%) Bookrunner(s)
Arbor Realty Trust US 17/07/2018 US$130.0m US$15.0m 3y 5.25 10.0 JP Morgan, JMP Securities
Calamp US 17/07/2018 US$200.0m US$30.0m 7y 2.00 30.0 JP Morgan, Goldman Sachs, Jefferies
Encore Capital US 17/07/2018 US$150.0m US$22.5m 5y 4.50 25.0 SunTrust Robinson Humphrey, Credit Suisse
Redfin US 18/07/2018 US$125.0m US$18.8m 5y 1.75 30.0 Goldman Sachs, BAML, RBC Capital Markets
GLOBAL CONVERTIBLE OFFERINGS
BOOKRUNNERS: 1/1/2018 TO DATE
Managing No of Total Share
bank or group issues US$(m) (%)
1 Goldman Sachs 41 8,991.83 13.6
2 JP Morgan 43 6,481.58 9.8
3 Morgan Stanley 40 6,094.08 9.2
4 BAML 29 4,537.58 6.8
5 Citigroup 19 3,433.92 5.2
6 Credit Suisse 18 2,677.31 4.0
7 Deutsche Bank 14 2,576.35 3.9
8 UBS 7 2,268.82 3.4
9 Barclays 14 2,113.22 3.2
10 BNP Paribas 11 1,503.79 2.3
Total 230 66,297.32
Including exchangeables.
Source: Thomson Reuters SDC code: C9
GLOBAL CONVERTIBLE OFFERINGS – EMEA
BOOKRUNNERS: 1/1/2018 TO DATE
Managing No of Total Share
bank or group issues US$(m) (%)
1 UBS 3 1,849.73 18.4
2 SG 7 1,072.57 10.7
3 JP Morgan 6 1,069.08 10.6
4 Deutsche Bank 4 1,022.29 10.2
5 Citigroup 5 792.52 7.9
6 BNP Paribas 6 673.63 6.7
7 Goldman Sachs 5 632.75 6.3
8 Morgan Stanley 3 399.50 4.0
9 BAML 3 385.75 3.8
10 HSBC 3 343.25 3.4
Total 29 10,069.81
Including exchangeables.
Source: Thomson Reuters SDC code: C09dALL INTERNATIONAL US CONVERTIBLES
BOOKRUNNERS: 1/1/2018 TO DATE
Managing No of Total Share
bank or group issues US$(m) (%)
1 Morgan Stanley 31 4,734.26 15.9
2 Goldman Sachs 29 4,651.31 15.6
3 JP Morgan 32 4,364.91 14.7
4 BAML 24 3,804.88 12.8
5 Citigroup 12 2,305.60 7.7
6 Barclays 11 1,809.97 6.1
7 Wells Fargo 10 1,392.38 4.7
8 Deutsche Bank 7 969.83 3.3
9 RBC 6 858.45 2.9
10 Credit Suisse 8 814.67 2.7
Total 77 29,751.87Source: Thomson Reuters SDC code: C9a